0000000000904945

AUTHOR

Nina Hohmann

showing 2 related works from this author

WITHDRAWN: Stability of cerebral activation patterns in patients with first-episode schizophrenia and a healthy control group using functional MRI

2011

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.

medicine.medical_specialtybusiness.industryInternal medicineHealthy controlMedicineRadiology Nuclear Medicine and imagingIn patientGeneral MedicineFirst episode schizophreniabusinessEuropean Journal of Radiology
researchProduct

Association of Low Striatal Dopamine D2Receptor Availability With Nicotine Dependence Similar to That Seen With Other Drugs of Abuse

2008

All drugs of abuse induce a phasic dopamine release within the striatum that does not undergo habituation. Prolonged substance consumption impairs the natural function of the mesolimbic dopamine system, as shown by a decrease in the availability of striatal dopamine 2 (D(2)) receptors in patients suffering from cocaine, heroin, amphetamine, and alcohol dependence. However, it is unclear whether similar changes can also be observed in heavy-smoking nicotine-dependent smokers.In vivo D(2)/D(3) receptor availability was determined with [ (18)F]fallypride positron emission tomography in 17 heavy-smoking nicotine-dependent subjects and in 21 age-matched never-smoking comparison subjects. The smo…

AdultMaleFluorine Radioisotopesmedicine.medical_specialtyPyrrolidinesSubstance-Related DisordersStriatumGyrus CinguliBasal GangliaFunctional LateralityNicotineDopamineInternal medicineDopamine receptor D2medicineHumansCarbon RadioisotopesAmphetamineReceptors Dopamine D2PutamenSmokingReceptors Dopamine D3Tobacco Use DisorderTemporal LobeSubstance Withdrawal SyndromeBehavior AddictivePsychiatry and Mental healthEndocrinologyFallyprideDopamine receptorPositron-Emission TomographyBenzamidesPsychologymedicine.drugAmerican Journal of Psychiatry
researchProduct